• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

    120.50 -6.31 (-4.98%)
    Streaming Delayed Price Updated: 3:30 PM EDT, Oct 10, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about GeneDx Holdings Corp. - Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
    Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms 
    From GeneDx Holdings Corp.; PacBio
    Via GlobeNewswire
    GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options
    Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patients 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Recap: GeneDx Hldgs Q1 Earnings
     
    Via Benzinga
    Earnings Preview: GeneDx Hldgs
     
    Via Benzinga
    GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
    Eight state Medicaid programs now cover rWGS in the pediatric inpatient setting, with active bills in other states 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Why Shares of GeneDx Dropped Wednesday
    The potential of a reverse split concerned investors. 
    Via The Motley Fool
    GeneDx Holdings's Earnings: A Preview
     
    Via Benzinga
    GeneDx to Participate in Upcoming Investor Conferences in June
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
    Keynote session to highlight value of GeneDx genomic data and clinical insights to accelerate genetic neurodevelopmental disorder pipeline for Mahzi Therapeutics 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 199 companies reached new 52-week lows. 
    Via Benzinga
    GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option
    New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Earnings Scheduled For May 9, 2023
    Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
    Via Benzinga
    GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    Why GeneDx Holdings Stock Lagged the Market Today
    A financial-engineering move about to be made by the company is an indication of some deep and challenging problems. 
    Via The Motley Fool
    GeneDx Announces Reverse Stock Split
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    It's time for another dive into the biggest pre-market stock movers with all the hot topics traders need to know about on Friday! 
    Via InvestorPlace
    Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. 
    Via Benzinga
    First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    The 7 Worst Stocks to Buy Now
    With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now. 
    Via InvestorPlace
    GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
    New research released at ACMG Annual Clinical Genetics Meeting reiterates the superiority of exome sequencing’s role in shortening the diagnostic odyssey 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.